TV coverage of EchoLaser for BPH (Benign Prostatic Hyperplasia) on RAI, Italian state television. Prof. Pierluigi Bove illustrates the benefits of this new and fast emerging technology.
Prof. Bove was one of the first users of EchoLaser and is the principal investigator of the first randomized clinical trial on this application: enrollment was closed and its publication is expected to be out in 2023.